Shanghai Pharmaceuticals announces restricted period for stock options

Shanghai Pharmaceuticals Holding has announced a restriction on the exercise of stock options for participants in its 2019 A-Share stock option incentive plan. According to the announcement, the restriction will be in effect from July 9, 2025, to July 18, 2025, during which time all participants of the incentive program will be barred from exercising their options. This restriction is part of the third exercise window for the reserved stock options, which is scheduled to run from February 8, 2025, to February 7, 2026. The company stated that it would manage the restricted exercise related matters in accordance with regulations.